Latest News about BCYC
Recent news which mentions BCYC
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
From Benzinga
Looking Into Bicycle Therapeutics's Return On Capital Employed
November 23, 2022
Tickers
BCYC
From Benzinga
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2022
August 31, 2022
From Benzinga
Looking Into Bicycle Therapeutics's Return On Capital Employed
August 22, 2022
Tickers
BCYC
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Monday
June 06, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
May 27, 2022
From Benzinga
B. Riley Securities Downgrades Rating to Neutral for Bicycle Therapeutics, Lowers Price Target To $33
April 13, 2022
Tickers
BCYC
From Benzinga
From Benzinga
Here's Why Bicycle Therapeutics Stock Looks Ill Today
April 11, 2022
From Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 11, 2022
From Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
From Benzinga
Why Bicycle Therapeutics Stock Is Soaring Today
April 08, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 08, 2022
From Benzinga
Bicycle Therapeutics's Return On Capital Employed Overview
March 04, 2022
Tickers
BCYC
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.